Medpace Holdings, Inc.
MEDP
$298.55
-$4.33-1.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.10% | 0.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.10% | 0.61% | |||
| Cost of Revenue | 6.14% | -2.34% | |||
| Gross Profit | 3.17% | 2.02% | |||
| SG&A Expenses | 27.43% | -7.69% | |||
| Depreciation & Amortization | -7.67% | -0.16% | |||
| Other Operating Expenses | 6.11% | -1.05% | |||
| Total Operating Expenses | 8.23% | -2.34% | |||
| Operating Income | -9.46% | 11.67% | |||
| Income Before Tax | -11.74% | 12.72% | |||
| Income Tax Expenses | -78.80% | -24.55% | |||
| Earnings from Continuing Operations | -2.07% | 21.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.07% | 21.36% | |||
| EBIT | -9.46% | 11.67% | |||
| EBITDA | -9.35% | 10.93% | |||
| EPS Basic | -0.27% | 21.75% | |||
| Normalized Basic EPS | -10.11% | 13.09% | |||
| EPS Diluted | -0.09% | 22.04% | |||
| Normalized Diluted EPS | -9.82% | 13.48% | |||
| Average Basic Shares Outstanding | -1.80% | -0.33% | |||
| Average Diluted Shares Outstanding | -2.12% | -0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||